Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-014739
Filing Date
2025-02-18
Accepted
2025-02-18 16:03:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 15498
  Complete submission text file 0001104659-25-014739.txt   17479
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

EIN.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Subject) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92776 | Film No.: 25634779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)